This type of malignancy is caused by cancerous cells in the breast tissue that tend to spread to the surrounding tissue. Ibrance has the capacity to block cyclin-dependent kinases (CDKs) 4 and 6, two molecules responsible for cancer cell proliferation.

“The addition of palbociclib to letrozole provides a novel treatment option to women diagnosed with metastatic breast cancer,” said the director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research, Richard Pazdur, M.D., in a press release from the agency. “The FDA is committed to expediting marketing approval of cancer drugs through our accelerated approval regulations.”

Pfizer conducted a study including 165 postmenopausal women with ER-positive, HER2-negative advanced breast cancer, which had not previously been treated for advanced disease. These women were randomly administrated either Ibrance in combination with letrozole or letrozole alone. The results revealed that ibrance and letrozole improved survival for 20.2 months, without disease progression, while letrozole only improved survival for a median of 10.2 months.

[adrotate group=”3″]

Ibrance is a therapy used in combination with letrozole, another drug that has already been approved by the FDA for the treatment of a series of breast cancer types in postmenopausal female patients. Pfizer’s drug had already been granted the FDA’s designation of breakthrough therapy due to its results of preliminary studies conducted, revealing the drug’s efficacy when compared to currently available therapies. In addition, the drug had also been granted priority review status, a designation that gives expedited review to drugs expected to improve safety or effectiveness in the treatment of a serious condition or meet an unmet medical need.

Breast Cancer News

Disclaimer:

Breast Cancer News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Pin It on Pinterest

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more